All Stories

  1. Potentiometric titration, biomolecular interactions, and docking insights of N-heterocyclic carbene gold(I) complexes derived from the marine betaine 1,3-dimethylimidazolium-4-carboxylate
  2. Quercetin, Catechin, and Diosmin as Modulators of Haloperidol–HSA Interactions: A Biophysical and Computational Study
  3. Analysis of the Lipophilicity and HSA Binding Profile of Biologically Relevant 2‐Mercaptobenzoic Acid Derivatives
  4. Unraveling the binding mechanism of olanzapine with human serum transferrin: a multispectroscopic and computational investigation
  5. The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach
  6. Synthesis, comprehensive characterization and investigation of biological properties of newly synthesized Pt(II)-aminothiazole complexes: Combining experimental and computational approach
  7. Linamarin Binding to Human Serum Albumin. A Spectroscopic and Molecular Docking Approach
  8. Investigation of the interaction between S-isoalkyl derivatives of the thiosalicylic acid and human serum albumin
  9. Study of Antipsychotic Drug Lurasidone Binding to Human Serum Albumin by Multispectroscopic and Molecular Docking Methods
  10. Exploring heterometallic bridged Pt(II)-Zn(II) complexes as potential antitumor agents
  11. Synthesis, characterization and investigating the binding mechanism of novel coumarin derivatives with human serum albumin: Spectroscopic and computational approach
  12. Effect of Caffeine and Flavonoids on the Binding of Tigecycline to Human Serum Albumin: A Spectroscopic Study and Molecular Docking
  13. Influence of the caffeine on the interaction between haloperidol and human serum albumin: Spectroscopic and molecular docking approach
  14. Synthesis, characterization, HSA/DNA binding, cytotoxicity study, and antimicrobial activity of new palladium(II) complexes with some esters of (S,S)-propylenediamine-N,N'-di-2-(3-methyl)butanoic acid
  15. Interaction between olanzapine and human serum albumin and effect of metal ions, caffeine and flavonoids on the binding: A spectroscopic study
  16. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η6-p-cymene)Cl2(L)] complexes
  17. Ruthenium(II) Complexes of Isothiazole Ligands: Crystal Structure, HSA/DNA Interactions, Cytotoxic Activity and Molecular Docking Simulations
  18. Spectroscopic studies on the drug–drug interaction: the influence of fluoroquinolones on the affinity of tigecycline to human serum albumin and identification of the binding site
  19. Homo- and hetero-dinuclear Pt(ii)/Pd(ii) complexes: studies of hydrolysis, nucleophilic substitution reactions, DNA/BSA interactions, DFT calculations, molecular docking and cytotoxic activity
  20. Rhodium(III) in a cage of the 1,3-propanediamine-N,N,N′-triacetate chelate: X-ray structure, solution equilibria, computational study and biological behavior
  21. Further insights into ruthenium(II) piano-stool complexes with N-alkyl imidazoles
  22. Interaction of haloperidol with human serum albumin.
  23. Prevalence of Prolonged QTC Interval in Patients Taking Psychopharmacs
  24. The Effect of Tigecycline on the Binding of Fluoroquinolones to Human Serum Albumin
  25. Stereospecific ligands and their complexes. XXIV. Synthesis, characterization and some biological properties of Pd(ii) and Pt(ii) complexes with R2-S,S-eddtyr
  26. The Evaluation of Angiotensin-Converting Enzyme Inhibitors in Renal Elimination with Selected Molecular Descriptors
  27. Estimation of plasma protein binding of selected antipsychotics using computed molecular properties
  28. Assessment of the relationship between the molecular properties of calcium channel blockers and plasma protein binding data
  29. Synthesis, structural analysis, solution equilibria and biological activity of rhodium(iii) complexes with a quinquedentate polyaminopolycarboxylate
  30. Relationship between the bioavailability and molecular properties of angiotensin II receptor antagonists
  31. Synthesis and characterisation of bismacrocyclic DO3A-amide derivatives – an approach towards metal-responsive PARACEST agents
  32. Study of inclusion complex of β-cyclodextrin and levofloxacin and its effect on the solution equilibria between gadolinium(III) ion and levofloxacin
  33. The influence of certain molecular descriptors of fecal elimination of angiotensin II receptor antagonists
  34. The effect of the molecular properties of calcium channel blockers on their elimination route
  35. Interaction between tigecycline and human serum albumin in aqueous solution
  36. Synthesis of novel palladium(ii) complexes with oxalic acid diamide derivatives and their interaction with nucleosides and proteins. Structural, solution, and computational study
  37. Kinetics, mechanism, and equilibrium studies of the reactions between a ruthenium(II) complex and some nitrogen- and sulfur-donor nucleophiles
  38. Configurational, LFDFT and NBO analysis of chromium(III) complexes of edta-type ligands
  39. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe Docking simulation
  40. Equilibrium studies between some transition metal ions and Me6[14]dieneN4 ligand
  41. HPLC analysis, antimicrobial and antioxidant activities of Daphne cneorum L.
  42. Antiproliferative activity and QSAR studies of a series of new 4-aminomethylidene derivatives of some pyrazol-5-ones
  43. Equilibrium studies on complex formation reactions of dichlorido[(R,R)-trans-1,2-diaminocyclohexane]platinum(II) complex with ligands of biological significance
  44. Equilibrium studies of the reactions of palladium(ii) bis(imidazolin-2-imine) complexes with biologically relevant nucleophiles. The crystal structures of [(TLtBu)PdCl]ClO4 and [(BLiPr)PdCl2]
  45. Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(ii) and Mo(vi). Thermodynamic stability and insulin-mimetic activity
  46. Acid-base equilibria of the Zn(II) and Fe(III) complexes with condensation products of 2-acetylpyridine and the dihydrazide of oxalic and malonic acid
  47. Equilibrium and 1H NMR Kinetic Study of the Reactions of Dichlorido [S-Methyl-L-Cysteine(N,S)]Platinum(II) Complex with Some Relevant Biomolecules
  48. Biologically relevant O,S-donor compounds. Synthesis, molybdenum complexation and xanthine oxidase inhibition
  49. Solution Equilibria between Aluminum(III) Ion and some Fluoroquinolone Family Members. Spectroscopic and Potentiometric Study
  50. Potentiometric and Multinuclear Magnetic Resonance Study of the Solution Equilibria Between Aluminium(III) Ion and L-Aspartic Acid
  51. Potentiometric Study of the Effect of Sodium Dodecylsulfate and Dioxane on the Hydrolysis of the Aluminum(III) Ion
  52. Equilibrium, kinetic and HPLC study of the reactions between platinum(ii) complexes and DNA constituents in the presence and absence of glutathione
  53. Solution Equilibria between Aluminum(III) Ion and L-histidine or L-tyrosine
  54. THE EFFECT OF SURFACE ACTIVE SUBSTANCES ON HYDROLYSIS OF ALUMINIUM(III) ION
  55. STUDY OF EQUILIBRIA IN ALUMINUM(III) - L-GLUTAMIC ACID OR -L-SERINE SOLUTIONS
  56. Hydrolysis of the zinc(II) ion in sodium nitrate, chloride and perchlorate medium: the effect of the anionic medium
  57. Complex formation equilibria in iron(III)-L-alanine system
  58. Study of Equilibria in the Aluminium(III)-Glycine and -Alanine Systems